clinical trial · NCT07417774
Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic
Glioblastoma (GBM)
brief summary
The goal of this sub-study of the RESTORE trial is to identify biomarkers associated with tumor hypoxia, identify biomarkers that differentiate pseudoprogression from true progression, and correlate biomarkers with clinical outcomes.
started
Dec 8, 2025
primary completion
Dec 1, 2027
completion
Dec 1, 2030
last updated
Feb 18, 2026
detailed description
Blood samples for liquid biopsy will be collected at the same time as the scheduled blood draws in the RESTORE study and analyzed by FYR Diagnostics.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol